pharma · Colonic disease
Norgine
Norgine Pty.
Norgine Pty is a pharma organization headquartered in Amsterdam, AU. Primary therapeutic focus areas include Colonic disease. NovaPharmaNews links 1 clinical program(s), 2 drug profile(s), and 0 patent record(s) to this
Amsterdam, NL HQ
1906 Founded
1,160 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Amsterdam, NL
- Founded
- 1906
- Employees
- 1,160
- Programs
- 1
- Drugs
- 3
- Patents
- 0
NER1006-01/2025
Phase 3 · small molecule · Colonic disease
NER1006-01/2025 for Colonic disease is a Phase 3 program (small_molecule) at Norgine Pty. with 1 ClinicalTrials.gov record(s).
Internal code NER1006-01/2025
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Norgine Pty.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Colonic disease
- Status
- active
- Trials
- 1